-
Innovation Ranking
NewInnovation Ranking – Pro-Dex Inc
Pro-Dex Inc (Pro-Dex) is a medical device company that manufactures and markets surgical devices. The company’s products include motion control, finished medical devices, micro air-motors, plastic injection molding, dental products and torque wrenches. Its dental products comprise DLS handpiece system, oral surgery handpiece and prophy plus. Pro-Dex offers services such as design and technical drafting, electronics and software, mechanical engineering and design, precision machining and assembly, quality and compliance, testing, prototyping and validation, and precision injection molding. It serves healthcare,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Peritoneal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Peritoneal Cancer Drug Details: PRO-1184 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1107 in Ureter Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1107 in Ureter Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1107 in Ureter Cancer Drug Details: PRO-1107 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1107 in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1107 in Peritoneal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1107 in Peritoneal Cancer Drug Details: PRO-1107 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1107 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1107 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1107 in Gastric Cancer Drug Details: PRO-1107 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1107 in Bladder Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1107 in Bladder Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1107 in Bladder Cancer Drug Details: PRO-1107 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1107 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1107 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1107 in Solid Tumor Drug Details: PRO-1107 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1107 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1107 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1107 in Endometrial Cancer Drug Details: PRO-1107 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Fallopian Tube Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Fallopian Tube Cancer Drug Details: PRO-1184 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Epithelial Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Epithelial Ovarian Cancer Drug Details: PRO-1184 is under development...